192 related articles for article (PubMed ID: 34118336)
1. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems.
Bhaskaran NA; Kumar L
J Control Release; 2021 Aug; 336():16-39. PubMed ID: 34118336
[TBL] [Abstract][Full Text] [Related]
2. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives.
Banerjee A; Pathak S; Subramanium VD; G D; Murugesan R; Verma RS
Drug Discov Today; 2017 Aug; 22(8):1224-1232. PubMed ID: 28545838
[TBL] [Abstract][Full Text] [Related]
3. Oral Nano-Delivery Systems for Colon Targeting Therapy.
Zhang T; Zhu G; Lu B; Peng Q
Pharm Nanotechnol; 2017; 5(2):83-94. PubMed ID: 28440202
[TBL] [Abstract][Full Text] [Related]
4. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
7. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
Ma Y; Coombes AG
J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
[TBL] [Abstract][Full Text] [Related]
8. Advances in colon-targeted nano-drug delivery systems: challenges and solutions.
Naeem M; Awan UA; Subhan F; Cao J; Hlaing SP; Lee J; Im E; Jung Y; Yoo JW
Arch Pharm Res; 2020 Jan; 43(1):153-169. PubMed ID: 31989477
[TBL] [Abstract][Full Text] [Related]
9. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer.
Kanthamneni N; Chaudhary A; Wang J; Prabhu S
Int J Oncol; 2010 Jul; 37(1):177-85. PubMed ID: 20514409
[TBL] [Abstract][Full Text] [Related]
11. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
[TBL] [Abstract][Full Text] [Related]
12. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
13. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
14. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.
Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV
J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062
[TBL] [Abstract][Full Text] [Related]
15. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
[TBL] [Abstract][Full Text] [Related]
16. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery.
Kumar S; Sharma B; Bhardwaj TR; Singh RK
Anticancer Agents Med Chem; 2021; 21(3):383-392. PubMed ID: 32781967
[TBL] [Abstract][Full Text] [Related]
18. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
Wang K; Shen R; Meng T; Hu F; Yuan H
Molecules; 2022 May; 27(9):. PubMed ID: 35566331
[TBL] [Abstract][Full Text] [Related]
19. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer.
Hasani-Sadrabadi MM; Taranejoo S; Dashtimoghadam E; Bahlakeh G; Majedi FS; VanDersarl JJ; Janmaleki M; Sharifi F; Bertsch A; Hourigan K; Tayebi L; Renaud P; Jacob KI
Adv Mater; 2016 Jun; 28(21):4134-41. PubMed ID: 27001745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
